ScottDLeeMD

Gastroenterology • Seattle, WA

Associate Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
1959 NE Pacific St
Seattle, WA 98195
Phone+1 206-598-4377

Fax+1 206-598-4732

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994

Certifications & Licensure

WA State Medical License 1997 - 2025
IL State Medical License 2000 - 2002
American Board of Internal Medicine Gastroenterology

Clinical Trials

Asacol Dosing Study for Active Ulcerative Colitis Start of enrollment: 2003 Jun 01
Completed
Phase 4
Induction of Clinical Response Using Rifaximin in Crohn's Disease Start of enrollment: 2008 Nov 01
Completed
Phase 2
Study of Cimzia for the Treatment of Ulcerative Colitis Start of enrollment: 2010 Dec 01
Completed
Phase 2

Publications & Presentations

PubMed

2 citations
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.
Geert D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, Bruce E Sands, Scott Lee
Inflammatory Bowel Diseases. 2024-12-05
6 citations
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Bruce E Sands, Geert D'Haens, David B Clemow, Peter M Irving, Jordan T Johns
Inflammatory Bowel Diseases. 2024-12-05
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Bruce E Sands, Geert D'Haens, David B Clemow, Peter M Irving, Jordan T Johns
Inflammatory Bowel Diseases. 2024-10-25